Follow-up data for Kodiak's KSI-101 from the APEX study showed continued strengthening of clinical effect (≥90% of patients achieving absence of intraretinal and subretinal ...

Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotechnology company committed to researching, developing and commercializing transformative therapeutics, announced today follow-up ...
MarketWatch

Crude Oil WTI (NYM $/bbl) Front Month

2-Year U.S. Treasury Note Continuous Contract $104.141-0.004 0.00% 5-Year U.S. Treasury Note Continuous Contract $109.227-0.008-0.01% 10-Year U.S. Treasury Note Continuous Contract $112.656-0.031-0.03 ...